IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer
City of Hope Medical Center
City of Hope Medical Center
Roswell Park Cancer Institute
Beijing Biotech
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
Mayo Clinic
Essen Biotech
M.D. Anderson Cancer Center